Domainex, a UK-based drug discovery company, has raised £1.5m ($2m) to accelerate research from investors including University College London Business (UCLB). The firm had a first close in December, which was also joined in participation by venture firm Bury Fitzwilliam-Lay and Partners and led by Longbow Capital. A second close is planned in April for…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
